What’s Next For Crispr After Its ‘Historic’ Gene-Editing Approval?
Crispr Therapeutics (CRSP) just executed on a moonshot goal as it recently won U.K. approval for the first gene-editing treatment ever. The move sent CRSP stock sky-high, and now the…